Literature DB >> 15486870

Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines.

Hugh C Rayner1, Anatole Besarab, Wendy W Brown, Alex Disney, Akira Saito, Ronald L Pisoni.   

Abstract

BACKGROUND: The Kidney Disease Outcomes Quality Initiative Guidelines for Vascular Access in hemodialysis patients recommend native arteriovenous (AV) fistulae over AV grafts or catheters for permanent vascular access. They recommend letting fistulae mature > or =1 month before cannulation.
METHODS: The Dialysis Outcomes and Practice Patterns Study (DOPPS) provides an unparalleled means to examine vascular access practice patterns and guidelines internationally, with particular attention to associations with mortality risk.
RESULTS: Most patients in Europe and Japan dialyze through AV fistulae and very few use AV grafts; in the United States, more patients use grafts than fistulae. Patients who receive nephrologic care for over 30 days before starting dialysis have significantly higher chances of commencing via AV fistula. Medical directors of dialysis facilities in the United States commonly prefer grafts; in Europe and Japan, most prefer fistulae. In the United States, there is a relatively long average time between fistula creation and cannulation but significantly worse fistula survival than that seen in Europe. Tunneled catheters pose a higher mortality risk than permanent accesses and are associated with increased risk of failure of a subsequent fistula. The percentage of prevalent patients in the DOPPS countries using catheters has increased in recent years. DOPPS data suggest that performance in some countries falls short of practices achieved in other countries. AV fistula use is low in the United States but has been improving. The trend of increasing use of catheters in most countries is discouraging.
CONCLUSION: The DOPPS will continue to monitor practice trends and explore whether greater application of guidelines will lead to fewer access complications and improved longevity for hemodialysis patients.

Entities:  

Mesh:

Year:  2004        PMID: 15486870     DOI: 10.1053/j.ajkd.2004.08.007

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  34 in total

1.  Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States.

Authors:  Cristina M Arce; Aya A Mitani; Benjamin A Goldstein; Wolfgang C Winkelmayer
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-23       Impact factor: 8.237

2.  Outcomes of initial hemodialysis vascular access in patients initiating dialysis with a tunneled catheter.

Authors:  Timothy Copeland; Peter Lawrence; Karen Woo
Journal:  J Vasc Surg       Date:  2019-05-27       Impact factor: 4.268

3.  Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case-control study in hemodialysis patients.

Authors:  Mireille El Ters; Gregory J Schears; Sandra J Taler; Amy W Williams; Robert C Albright; Bernice M Jenson; Amy L Mahon; Andrew H Stockland; Sanjay Misra; Scott L Nyberg; Andrew D Rule; Marie C Hogan
Journal:  Am J Kidney Dis       Date:  2012-06-15       Impact factor: 8.860

Review 4.  The Biology of Hemodialysis Vascular Access Failure.

Authors:  Akshaar Brahmbhatt; Sanjay Misra
Journal:  Semin Intervent Radiol       Date:  2016-03       Impact factor: 1.513

5.  Comorbidities do not influence primary fistula success in incident hemodialysis patients: a prospective study.

Authors:  Wenjie Wang; Brendan Murphy; Serdar Yilmaz; Marcello Tonelli; Jennifer Macrae; Braden J Manns
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-07       Impact factor: 8.237

Review 6.  Neointimal hyperplasia associated with synthetic hemodialysis grafts.

Authors:  Li Li; Christi M Terry; Yan-Ting E Shiu; Alfred K Cheung
Journal:  Kidney Int       Date:  2008-07-30       Impact factor: 10.612

Review 7.  Challenges and novel therapies for vascular access in haemodialysis.

Authors:  Jeffrey H Lawson; Laura E Niklason; Prabir Roy-Chaudhury
Journal:  Nat Rev Nephrol       Date:  2020-08-24       Impact factor: 28.314

Review 8.  Vascular access in haemodialysis: strengthening the Achilles' heel.

Authors:  Miguel C Riella; Prabir Roy-Chaudhury
Journal:  Nat Rev Nephrol       Date:  2013-04-16       Impact factor: 28.314

9.  Factors associated with the receipt of antimicrobials among chronic hemodialysis patients.

Authors:  Graham M Snyder; Priti R Patel; Alexander J Kallen; James A Strom; J Kevin Tucker; Erika M C D'Agata
Journal:  Am J Infect Control       Date:  2016-05-13       Impact factor: 2.918

10.  Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER--a multicentre, prospective, observational cohort study.

Authors:  Rafael Pérez-García; Alejandro Martín-Malo; Joan Fort; Xavier Cuevas; Fina Lladós; Javier Lozano; Fernando García
Journal:  Nephrol Dial Transplant       Date:  2008-11-21       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.